Roche, OrbiMed And McKinsey's Entrepreneurship Competition Builds Platform For China's Young Biotech Community
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Seeking ways to tap into China's rich talent pool and spark local innovation, Roche, OrbiMed and McKinsey are hoping a SEED business competition can nurture entrepreneurs in China's biotech academic community
You may also be interested in...
Korean Biotechs Battle For Funding and Attention Underneath Chinese Shadow
SEOUL - Korean biotechs are producing siginificant R&D output, but there is a disconnect between local companies' scientific and financial success, and the country needs to utilize new models to build a viable biotech industry, according to panelists at Bio Korea 2010
Korean Biotechs Battle For Funding and Attention Underneath Chinese Shadow
SEOUL - Korean biotechs are producing siginificant R&D output, but there is a disconnect between local companies' scientific and financial success, and the country needs to utilize new models to build a viable biotech industry, according to panelists at Bio Korea 2010
Asia Spotlight: Roche's Joe McCracken On Early-stage Partnering In Asia
On the second Monday of each month, "The Pink Sheet" provides exclusive news and commentary on the Asia biopharma market from the editors of its affiliated online publication, PharmAsia News. Register at 1http://pharmasianews.elsevierbi.com/PAN_Trial_LP.html for a free trial.